• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Picroside Ⅱ protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by activating the P

Picroside Ⅱ protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by activating the P

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户：melaniezhao
【摘 要】
：
Background Picroside Ⅱ,an iridoid glucoside found in the root of Picrorhiza scrophulariiflora Pennell (Scrophulariaceae),has been demonstrated to reduce apoptosis in neuronal cells and other cell type
【作 者】
：
Meng Fanji Jiao Sumin Yu Bo 
【机 构】
：
Department of Cardiology,First Hospital of China Medical University,Shenyang,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
【发表日期】
：
2014年3期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Picroside Ⅱ,an iridoid glucoside found in the root of Picrorhiza scrophulariiflora Pennell (Scrophulariaceae),has been demonstrated to reduce apoptosis in neuronal cells and other cell types.However,whether picroside Ⅱ has a protective effect against cardiomyocyte apoptosis is poorly understood.
其他文献
Impact of disease extent on patients with unprotected left main coronary artery stenosis treated wit
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an altemative therapy to cardiac surgery for left main (LM) patients with low to mod
会议
Long-term outcomes of unprotected left main stenting with drug-eluting stent:data derived from a lar
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an alternative therapy to cardiac surgery for left main (LM) patients with low to mo
会议
Decreased pharmacodynamic effects from switching high-dose atorvastatin to rosuvastatin in senile Ch
Background Clopidogrel and statin are strongly recommended after percutaneous coronary intervention,and administration of high dose statin can notably improve prognosis in elder patients with high ris
会议
Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of DES in-stent restenos
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in small coronary arteries.The intention of this sub-group analysis is to compare the safety an
会议
Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of diffuse DES in-stent
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions.The intention of this subgroup analysis is to compare the safety and effecti
会议
Clinical impact of prolonged dual antiplatelet therapy for true bifurcation coronary artery lesion t
Background Twelve-month dual antiplatelet therapy (DAT) with aspirin and clopidogrel after drug-eluting stent (DES) implantation is routinely recommended.It is unclear if prolonged (＞ 12 months) DAT i
会议
Efficacy and safety of clopidogrel added proton pump inhibitors vs.clopidogrel in the treatment of c
Background The combination of clopidogrel added proton pump inhibitors after a percutaneous coronary intervention has been used in clincal therapy,but whether it is safe and effective should be furthe
会议
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
会议
Gender-specific prevalence and associated risk factors of prehypertension among rural children and a
Background Little is known about the prevalence and risk profile of prehypertension among Chinese children and adolescents.The aim of the present study was to investigate the prehypertensive status an
会议
Effect of anticoagulant therapy with fondaparinux sodium on limb ischemia in patients treated with i
Background The anticoagulation effect of fondaparinux sodium is equal to or slightly better than unfractionated heparin (UFH) or low molecular weight heparin (LMWH),and the application of fondaparinux
会议